Product NDC: | 13668-011 |
Proprietary Name: | Citalopram Hydrobromide |
Non Proprietary Name: | Citalopram Hydrobromide |
Active Ingredient(s): | 40 mg/1 & nbsp; Citalopram Hydrobromide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13668-011 |
Labeler Name: | Torrent Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078216 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071018 |
Package NDC: | 13668-011-05 |
Package Description: | 500 TABLET in 1 BOTTLE (13668-011-05) |
NDC Code | 13668-011-05 |
Proprietary Name | Citalopram Hydrobromide |
Package Description | 500 TABLET in 1 BOTTLE (13668-011-05) |
Product NDC | 13668-011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Citalopram Hydrobromide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071018 |
Marketing Category Name | ANDA |
Labeler Name | Torrent Pharmaceuticals Limited |
Substance Name | CITALOPRAM HYDROBROMIDE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |